Jan S. Moreb

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister et al. · New England Journal of Medicine · 2012 · 1.1K citations · Full text

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

María‐Victoria Mateos, Hilary Blacklock, Fredrik Schjesvold et al. · The Lancet Haematology · 2019 · 249 citations · Full text

Hematological Malignancy, Oncology, Hematology +6

ALDH1A1 and ALDH3A1 expression in lung cancers: Correlation with histologic type and potential precursors

Miten Patel, Li Lu, Dani S. Zander et al. · Lung Cancer · 2007 · 213 citations

Lung Cancers, Aldh3a1 Expression, Oncology +10

The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance

Jan S. Moreb, Deniz A. Uçar, Shuhong Han et al. · Chemico-Biological Interactions · 2011 · 201 citations · Full text

Aldo-keto Reductase, Health Sciences, Biochemistry +11

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

Anita D’Souza, Angela Dispenzieri, Baldeep Wirk et al. · Journal of Clinical Oncology · 2015 · 200 citations · Full text